Ngā hua rapu kaituhi :: APM

1

Therapeutic Drug Monitoring of Biologics for Inflammatory Bowel Disease mā Jean‐Frédéric Colombel, Brian G. Feagan, William J. Sandborn, Gert Van Assche, Anne Robinson

I whakaputaina 2011

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
2

Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from <scp>CHARM</scp> and <scp>ADHERE</scp> mā Remo Panaccione, J F Colombel, William J. Sandborn, Geert D’Haens, Qian Zhou, P Pollack, Roopal Thakkar, Anne Robinson

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
3

Serum Adalimumab Concentration and Clinical Remission in Patients with Crohnʼs Disease mā Yi‐Lin Chiu, David T. Rubin, Séverine Vermeire, Édouard Louis, Anne Robinson, Kathleen G. Lomax, Paul F. Pollack, Susan K. Paulson

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
4

Pharmacokinetics and Exposure–Efficacy Relationship of Adalimumab in Pediatric Patients with Moderate to Severe Crohnʼs Disease mā Shringi Sharma, Doerthe Eckert, Jeffrey S. Hyams, Sven Mensing, Roopal Thakkar, Anne Robinson, Joel R. Rosh, Frank M. Ruemmele, Walid M. Awni

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
5

Increased Risk of Malignancy With Adalimumab Combination Therapy, Compared With Monotherapy, for Crohn's Disease mā Mark T. Osterman, William J. Sandborn, Jean–Frédéric Colombel, Anne Robinson, Winnie Lau, Bidan Huang, Paul F. Pollack, Roopal Thakkar, James D. Lewis

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

Subgroup analysis of the placebo-controlled CHARM trial: Increased remission rates through 3years for adalimumab-treated patients with early Crohn's disease mā Stefanie Schreiber, Walter Reinisch, J F Colombel, William J. Sandborn, Daniël W. Hommes, Anne Robinson, B Huang, Kathleen G. Lomax, P Pollack

I whakaputaina 2012

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis mā Yasuo Suzuki, Satoshi Motoya, Hiroyuki Hanai, Takayuki Matsumoto, Toshifumi Hibi∥, Anne Robinson, Nael M. Mostafa, Jingdong Chao, Vipin Arora, Anne Camez, Roopal Thakkar, Mamoru Watanabe

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
8

Effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in patients with Crohn's disease or ulcerative colitis who had failed conventiona... mā J F Colombel, Bindia Jharap, William J. Sandborn, Brian G. Feagan, Laurent Peyrin–Biroulet, Samantha Eichner, Anne Robinson, Nael M. Mostafa, Qian Zhou, Roopal Thakkar

I whakaputaina 2016

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

One‐year maintenance outcomes among patients with moderately‐to‐severely active ulcerative colitis who responded to induction therapy with adalimumab: subgroup analyses from ULTRA... mā William J. Sandborn, J F Colombel, Geert D’Haens, Gert Van Assche, Douglas C. Wolf, Martina Kron, A. Lazar, Anne Robinson, Mei Yang, J. Chao, Roopal Thakkar

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
10

Characterisation of Mucosal Healing with Adalimumab Treatment in Patients with Moderately to Severely Active Crohn’s Disease: Results from the EXTEND Trial mā Walter Reinisch, Jean‐Frédéric Colombel, Geert D’Haens, William J. Sandborn, Paul Rutgeerts, Karel Geboes, Joel Petersson, Samantha Eichner, Qian Zhou, Anne Robinson, Holly A. Read, Roopal Thakkar

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
11

Long-term Efficacy and Safety of Adalimumab in Pediatric Patients with Crohnʼs Disease mā William A. Faubion, Marla C. Dubinsky, Frank M. Ruemmele, Johanna C. Escher, Joel R. Rosh, Jeffrey S. Hyams, Samantha Eichner, Yao Li, Nattanan Reilly, Roopal Thakkar, Anne Robinson, Andreas Lazar

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
12

Four-Year Maintenance Treatment With Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis: Data from ULTRA 1, 2, and 3 mā Jean–Frédéric Colombel, William J. Sandborn, Subrata Ghosh, Douglas C. Wolf, Remo Panaccione, Brian G. Feagan, Walter Reinisch, Anne Robinson, Andreas Lazar, Martina Kron, Bidan Huang, Martha Skup, Roopal Thakkar

I whakaputaina 2014

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
13

Effect of Adalimumab on Clinical Outcomes and Health-related Quality of Life Among Patients With Ulcerative Colitis in a Clinical Practice Setting: Results From InspirADA mā Simon Travis, Brian G. Feagan, Laurent Peyrin–Biroulet, Remo Panaccione, Silvio Danese, Andreas Lazar, Anne Robinson, Joel Petersson, Brandee Pappalardo, Mareike Bereswill, Naijun Chen, Song Wang, Martha Skup, Roopal Thakkar, Jingdong Chao

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
14

Adalimumab for the Treatment of Japanese Patients With Intestinal Behçet’s Disease mā Satoshi Tanida, Nagamu Inoue, Kiyonori Kobayashi, Makoto Naganuma, Fumihito Hirai, Bunei Iizuka, Kenji Watanabe, Keiichi Mitsuyama, Takuya Inoue, Yoshiaki Ishigatsubo, Yasuo Suzuki, Masakazu Nagahori, Satoshi Motoya, Shirô Nakamura, Vipin Arora, Anne Robinson, Roopal Thakkar, Toshifumi Hibi∥

I whakaputaina 2014

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
15

Long‐term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis mā Jean‐Frédéric Colombel, William J. Sandborn, Walter Reinisch, Laurent Peyrin–Biroulet, Remo Panaccione, P. Rutgeerts, Stephen B. Hanauer, Subrata Ghosh, Gert Van Assche, Anne Robinson, Winnie Lau, J. Maa, B Huang, Brandee Pappalardo, Holly A. Read

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
16

Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies: Randomized SERENE CD Trial Results mā Geert D’Haens, William J. Sandborn, Edward V. Loftus, Stephen B. Hanauer, Stefan Schreiber, Laurent Peyrin–Biroulet, Remo Panaccione, Julián Panés, Filip Baert, Jean‐Frédéric Colombel, Marc Ferrante, Édouard Louis, Alessandro Armuzzi, Qian Zhou, Venkata Sasikiran Goteti, Nael M. Mostafa, Thao Doan, Joel Petersson, Tricia Finney‐Hayward, Alexandra Song, Anne Robinson, Silvio Danese

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
17

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial mā Jean‐Frédéric Colombel, Remo Panaccione, Peter Bossuyt, Milan Lukáš, Filip Baert, Tomáš Vaňásek, Ahmet Danalıoğlu, Gottfried Novacek, Alessandro Armuzzi, Xavier Hébuterne, Simon Travis, Silvio Danese, Walter Reinisch, William J. Sandborn, Paul Rutgeerts, Daniël W. Hommes, Stefan Schreiber, Ezequiel Neimark, Bidan Huang, Qian Zhou, Paloma Méndez, Joel Petersson, Kori Wallace, Anne Robinson, Roopal Thakkar, Geert D’Haens

I whakaputaina 2017

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
18

Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study mā Brian G. Feagan, Julián Panés, Marc Ferrante, Arthur Kaser, Geert D’Haens, William J. Sandborn, Édouard Louis, Markus F. Neurath, Denis Franchimont, Olivier Dewit, Ursula Seidler, Kyung-Jo Kim, Christian P. Selinger, Steven J. Padula, Ivona Herichova, Anne Robinson, Kori Wallace, Jun Zhao, Mukul Minocha, Mohamed I. A. Othman, Adina Soaita, Sudha Visvanathan, David B. Hall, Wulf O. Böcher

I whakaputaina 2018

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
19

Higher vs Standard Adalimumab Induction and Maintenance Dosing Regimens for Treatment of Ulcerative Colitis: SERENE UC Trial Results mā Julián Panés, Jean‐Frédéric Colombel, Geert D’Haens, Stefan Schreiber, Remo Panaccione, Laurent Peyrin–Biroulet, Edward V. Loftus, Silvio Danese, Satoshi Tanida, Yusuke Okuyama, Édouard Louis, Alessandro Armuzzi, Marc Ferrante, Harald Vogelsang, Toshifumi Hibi∥, Mamoru Watanabe, J Lefèbvre, Tricia Finney‐Hayward, Yuri Sánchez González, Thao Doan, Nael M. Mostafa, Kimitoshi Ikeda, Wangang Xie, Bidan Huang, Joel Petersson, Jasmina Kalabic, Anne Robinson, William J. Sandborn

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
20

Association of Implementation of Practice Standards for Electrocardiographic Monitoring With Nurses’ Knowledge, Quality of Care, and Patient Outcomes mā Marjorie Funk, Kristopher P. Fennie, Kimberly E. Stephens, Jeanine May, Catherine Winkler, Barbara J. Drew, Barbara Borman, Stephanie Calcasola, Mary G. Carey, L. Currie, Leslie L. Davis, Eleanor Fitzpatrick, Rhonda Fleischman, Darice Hawkins, Elise Hazlewood, Rebecca Henry, Cindy Honess, Peggy Kalowes, Sharon Ann Kearns, Bobbi Leeper, Joseph Liggett, Paula Lusardi, Carol Lynn, Manbo Man, Kathleen McCauley, M. Hing, Anita Pang, Janet Parkosewich, JoAnne Phillips, Anne Robinson, Noraliza Salazar, Kristin E. Sandau, Cass Piper Sandoval, Prasama Sangkachand, Rose B. Shaffer, Heather Sherrard, Maureen Smith, Rebecca Stamm, Vickie Strang, Nancy Wen Sim Tee, K. J. Wells, Paula White

I whakaputaina 2017

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i: